Study: Intervention costs rise as glucose threshold is lowered

11/18/2013 | PhysiciansBriefing.com

Lowering the threshold for a normal fasting plasma glucose level may increase medical costs despite its potential benefit in diabetes prevention, CDC researchers noted in Diabetes Care. Researchers said lowering the glucose threshold may increase the cost per lifetime quality-adjusted life-year gained from $30,100 at 115 mg/dL to $115,800 at 90 mg/dL.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Chief, Product Review Branch
FDA/Center for Biologics Evaluation and Research
Silver Spring, MD
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ